Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Claritev (CTEV) Other financing activities (2020 - 2025)

Claritev has reported Other financing activities over the past 3 years, most recently at $4.3 million for Q1 2025.

For Q1 2025, Other financing activities changed N/A year-over-year to $4.3 million; the TTM value through Dec 2025 reached $4.3 million, up 593.82%, while the annual FY2025 figure was $4.3 million, 593.82% up from the prior year.
Other financing activities for Q1 2025 was $4.3 million at Claritev, up from $615000.0 in the prior quarter.
Over five years, Other financing activities peaked at $4.3 million in Q1 2025 and troughed at $615000.0 in Q4 2024.